NFL tight ends and prostate cancer survivor Bruce Arians star in a Super Bowl commercial promoting a new, finger-free PSA ...

Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard to treat or because oncologists are bad at spotting it. In large part, it's because people aren't ...

St. Elizabeth Healthcare As a New Year settles in, consider making small, meaningful changes to improve your life over the ...

Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).

The ctDNA test showed 79.2% sensitivity and 91.5% specificity for CRC detection in a diverse cohort. The study met primary end points but had limited sensitivity for advanced precancerous lesions.